-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c375f11-3dbc-4a12-aff4-856e7531927a&Preview=1 -
Date
6/21/2010 -
Company Name
CytoPherx -
Mailing Address
401 W. Morgan Rd. Ann Arbor, MI 48108 -
Company Description
CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.The Company’s products are custom, patent-protected configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient’s blood system. The Company is initially focused on acute renal failure (ARF), end-stage renal disease (ESRD) and acute inflammation induced by cardio pulmonary bypass (CPB) surgery.
-
Website
http://www.cytopherx.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed